Kornelia Geiβler

Title: Kornelia Geiβler: Innovator in Veterinary Pharmaceuticals

Introduction

Kornelia Geiβler is a notable inventor based in Kö'ln, Germany. She has made significant contributions to the field of veterinary pharmaceuticals, particularly in the development of endoparasiticidal agents for animals. Her work focuses on creating effective solutions that are easily accepted by pets such as dogs, cats, and horses.

Latest Patents

Kornelia Geiβler holds a patent for "Endoparasiticidal agents for voluntary oral ingestion by animals." This invention relates to pharmaceutical presentations that can be administered orally to animals, ensuring they are readily accepted. The patent addresses the need for effective endoparasiticides that can be used in veterinary medicine.

Career Highlights

Kornelia is associated with Bayer Animal Health GmbH, a leading company in the field of animal health. Her role at Bayer has allowed her to contribute to innovative solutions that enhance the well-being of animals. With her expertise, she has been able to develop products that meet the needs of both veterinarians and pet owners.

Collaborations

Throughout her career, Kornelia has collaborated with esteemed colleagues such as Jochen Kalbe and Michael Träubel. These partnerships have fostered an environment of innovation and have led to the successful development of new veterinary products.

Conclusion

Kornelia Geiβler's work in veterinary pharmaceuticals exemplifies her commitment to improving animal health through innovation. Her contributions, particularly in the area of endoparasiticides, highlight the importance of research and development in the field.